ACADSB Antibodies

Santa Cruz Biotechnology provides a broad selection of ACADSB monoclonal antibodies for research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACADSB, or acyl-CoA dehydrogenase, short/branched chain, plays a crucial role in the metabolism of fatty acids, particularly in the oxidation of short and branched-chain acyl-CoA esters. ACADSB is essential for maintaining energy homeostasis and is implicated in various metabolic disorders. Understanding ACADSB function has significant implications for metabolic disease research and potential therapeutic development. ACADSB expression patterns can be effectively analyzed across different tissues and experimental conditions. Investigating ACADSB interactions with other metabolic enzymes provides valuable insights into cellular energy regulation. Research focusing on ACADSB helps advance knowledge of fatty acid metabolism pathways and their impact on human health. Detailed characterization of ACADSB activity contributes to understanding metabolic disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of metabolic processes and disease mechanisms.